ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions

BACKGROUND: Expansion of type 2 innate lymphoid cells (ILC2s) in hypercholesterolaemic mice protects against atherosclerosis while different ILC2 subsets have been described (natural, inflammatory) based on their suppression of tumorigenicity 2 (ST2) and killer-cell lectin like receptor G1 (KLRG1) e...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Immunol
Auteurs principaux: Mantani, Polyxeni T., Dunér, Pontus, Ljungcrantz, Irena, Nilsson, Jan, Björkbacka, Harry, Fredrikson, Gunilla Nordin
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905041/
https://ncbi.nlm.nih.gov/pubmed/31823769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-019-0330-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires